NYSE: DINO
HF Sinclair CorpCIK 0001915657 · SIC 4610 · Pipelines (Except Natural Gas)
Mega
Revenue $26.9B
Assets $19.0B
as of Aug 27, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WOLF 10-K) is open in full — no account needed.
8-K
Filed Aug 26, 2026
· Period ending Aug 26, 2026
Summary not yet generated.
8-K
Filed Aug 5, 2026
· Period ending Aug 4, 2026
Summary not yet generated.
Partner
Trade DINO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed Jul 30, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jul 28, 2026
· Period ending Jul 28, 2026
Summary not yet generated.
10-Q
Filed May 1, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
10-K
Filed Feb 27, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
424B5
Filed Aug 13, 2025
Summary not yet generated.
424B5
Filed Aug 11, 2025
Summary not yet generated.
10-K
Filed Feb 20, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
424B5
Filed Jan 10, 2025
Summary not yet generated.
424B3
Filed Aug 5, 2024
Summary not yet generated.
424B3
Filed Oct 26, 2023
Summary not yet generated.
424B3
Filed Sep 21, 2022
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 30, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations (Unaudited)
(Unaudited, in millions except share and per share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Sales and other revenues (Note 3) | 10,390 | 6,784 | 17,513 | 13,154 |
| Operating costs and expenses: | ||||
| Cost of sales: (1) | ||||
| Cost of materials and other (2) | 8,133 | 5,440 | 14,113 | 10,916 |
| Lower of cost or market inventory valuation adjustments (Note 9) | 30 | 148 | (642) | 31 |
| Operating expenses | 654 | 572 | 1,278 | 1,168 |
| 8,817 | 6,160 | 14,749 | 12,115 | |
| Selling, general and administrative expenses (1) | 130 | 114 | 245 | 218 |
| Depreciation and amortization | 228 | 226 | 457 | 451 |
| Other operating expenses, net (Note 4) | 47 | 9 | 47 | 14 |
| Total operating costs and expenses | 9,222 | 6,509 | 15,498 | 12,798 |
| Income from operations | 1,168 | 275 | 2,015 | 356 |
| Other income (expense): | ||||
| Earnings of equity method investments | 6 | 10 | 14 | 21 |
| Interest income | 15 | 7 | 25 | 16 |
| Interest expense | (20) | (53) | (61) | (102) |
| Other income (expense), net (Note 5) | 3 | 7 | 18 | (46) |
| 4 | (29) | (4) | (111) | |
| Income before income taxes | 1,172 | 246 | 2,011 | 245 |
| Income tax expense (Note 11): | ||||
| Current | 249 | 32 | 345 | 32 |
| Deferred | 30 | 4 | 123 | 5 |
| 279 | 36 | 468 | 37 | |
| Net income | 893 | 210 | 1,543 | 208 |
| Less: net income attributable to noncontrolling interests | 1 | 2 | 3 | 4 |
| Net income attributable to HF Sinclair stockholders | 892 | 208 | 1,540 | 204 |
| Earnings per share attributable to HF Sinclair stockholders: | ||||
| Basic | 4.93 | 1.10 | 8.48 | 1.07 |
| Diluted | 4.93 | 1.10 | 8.48 | 1.07 |
| Average number of common shares outstanding (in thousands): | ||||
| Basic | 179,417 | 188,110 | 180,032 | 188,298 |
| Diluted | 179,417 | 188,110 | 180,032 | 188,298 |
Consolidated Balance Sheets
(In millions, except share data)
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 2,262 | 978 |
| Accounts receivable, net: Product and transportation | 1,595 | 1,033 |
| Crude oil resales | 150 | 103 |
| 1,745 | 1,136 | |
| Inventories: Crude oil and refined products (Note 9) | 2,917 | 2,214 |
| Materials, supplies and other | 359 | 359 |
| 3,276 | 2,573 | |
| Income taxes receivable | 2 | 47 |
| Prepayments and other | 102 | 78 |
| Total current assets | 7,387 | 4,812 |
| Properties, plants and equipment, at cost | 11,518 | 11,392 |
| Less: accumulated depreciation | (5,088) | (4,859) |
| 6,430 | 6,533 | |
| Operating lease right-of-use assets | 362 | 349 |
| Other assets: Turnaround costs | 876 | 883 |
| Goodwill | 2,978 | 2,978 |
| Equity method investments | 259 | 226 |
| Intangibles and other | 702 | 729 |
| 4,815 | 4,816 | |
| Total assets | 18,994 | 16,510 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 2,489 | 1,902 |
| Income taxes payable | 149 | 5 |
| Operating lease liabilities | 90 | 85 |
| Accrued liabilities (Note 10) | 1,020 | 493 |
| Total current liabilities | 3,748 | 2,485 |
| Long-term debt, net (Note 12) | 2,772 | 2,769 |
| Noncurrent operating lease liabilities | 297 | 289 |
| Deferred income taxes | 1,356 | 1,240 |
| Other long-term liabilities (Note 10) | 471 | 478 |
| Total liabilities | 8,644 | 7,261 |
| Commitments and Contingencies (Note 16) | ||
| Equity: | ||
| HF Sinclair stockholders’ equity: | ||
| Preferred stock, $1.00 par value 5,000,000 shares authorized; none issued | — | — |
| Common stock, $0.01 par value 320,000,000 shares authorized; 223,231,546 shares issued as of June 30, 2026 and December 31, 2025 | 2 | 2 |
| Additional capital | 6,021 | 6,008 |
| Retained earnings | 6,733 | 5,373 |
| Accumulated other comprehensive loss (Note 15) | (46) | (26) |
| Common stock held in treasury, at cost 45,447,697 and 41,443,642 shares as of June 30, 2026 and December 31, 2025 | (2,425) | (2,173) |
| Total HF Sinclair stockholders’ equity | 10,285 | 9,184 |
| Noncontrolling interests | 65 | 65 |
| Total equity | 10,350 | 9,249 |
| Total liabilities and equity | 18,994 | 16,510 |
Consolidated Statements of Cash Flows (Unaudited)
(Unaudited, in millions)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | 1,543 | 208 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 457 | 451 |
| Asset impairments | 47 | 1 |
| Lower of cost or market inventory valuation adjustments | (642) | 31 |
| Earnings of equity method investments, net of distributions | (12) | (1) |
| Loss on early extinguishment of debt | — | 16 |
| Gain on sale of assets | — | (1) |
| Loss on sale of equity method investment | — | 40 |
| Deferred income tax expense | 123 | 5 |
| Equity-based compensation expense | 15 | 13 |
| Change in fair value derivative instruments | (56) | 40 |
| (Increase) decrease in current assets: | ||
| Accounts receivable | (609) | (96) |
| Inventories | (65) | (25) |
| Income taxes receivable | 45 | 17 |
| Prepayments and other | (7) | 3 |
| Increase (decrease) in current liabilities: | ||
| Accounts payable | 608 | (22) |
| Income taxes payable | 145 | — |
| Accrued liabilities | 551 | 156 |
| Turnaround expenditures | (175) | (284) |
| Other, net | (1) | (54) |
| Net cash provided by operating activities | 1,967 | 498 |
| Cash flows from investing activities: | ||
| Additions to properties, plants and equipment | (220) | (197) |
| Acquisitions, net of cash acquired | (38) | — |
| Investment in equity method investment | (22) | — |
| Proceeds from sale of assets | — | 2 |
| Other, net | — | 2 |
| Net cash used for investing activities | (280) | (193) |
| Cash flows from financing activities: | ||
| Purchase of treasury stock, inclusive of excise tax | (255) | (50) |
| Dividends | (180) | (190) |
| Payments on financing arrangements | (25) | — |
| Distributions to noncontrolling interests | (3) | (6) |
| Proceeds from financing arrangements | 71 | — |
| Redemption of senior notes | — | (1,007) |
| Repayments under credit agreements | — | (350) |
| Proceeds from issuance of senior notes | — | 1,394 |
| Deferred financing costs | — | (19) |
| Other, net | (8) | (11) |
| Net cash used for financing activities | (400) | (239) |
| Effect of exchange rate on cash flow | (3) | 8 |
| Cash and cash equivalents: | ||
| Net change for the period | 1,284 | 74 |
| Cash and cash equivalents at beginning of period | 978 | 800 |
| Cash and cash equivalents at end of period | 2,262 | 874 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | (83) | (63) |
| Decrease in accrued and unpaid capital expenditures | (16) | (8) |
Amounts as printed on the EDGAR/iXBRL face — (Unaudited, in millions except share and per share data); (In millions, except share data); (Unaudited, in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗